Lv1
20 积分 2023-08-27 加入
A multifactorial risk scoring system for the prediction of early relapse in CMML patients with allo-HSCT: a nationwide representative multicenter study
17小时前
已完结
Prognostic impact of co-mutations in adults with IDH1/2-mutated acute myeloid leukemia
22小时前
已关闭
Comprehensive analysis of clinical, pathological, and molecular features in chronic myelomonocytic leukemia: frequent ASXL1 and NRAS mutations and higher mutation burden in myeloproliferative CMML compared to myelodysplastic CMML
22天前
已完结
Influence of co-mutational patterns in disease phenotype and clinical outcomes of chronic myelomonocytic leukemia
28天前
已完结
Comprehensive analysis of clinical, pathological, and molecular features in chronic myelomonocytic leukemia: frequent ASXL1 and NRAS mutations and higher mutation burden in myeloproliferative CMML compared to myelodysplastic CMML
28天前
已完结
Pre-emptive therapeutic decisions based on measurable residual disease status in acute myeloid leukemia: ready for prime time?
3个月前
已完结
Validation and refinement of the 2022 European LeukaemiaNet genetic risk classification of acute myeloid leukaemia patients receiving allogeneic haematopoietic cell transplantation
4个月前
已完结
Impact of somatic gene mutations on the risk of thrombosis in myelofibrosis
4个月前
已完结
Managing the unmanageable: evidence-driven approaches to real-world patient prototypes of TP53-mutant myelodysplastic neoplasms and acute myeloid leukemia
4个月前
已完结
Current myeloproliferative neoplasm scoring systems for clinical practice
4个月前
已关闭
皖公网安备34019202002308
